Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer

SINCE the initial observation by Trousseau in 1868 relating thrombotic phenomena to cancer, 1 numerous studies have addressed the relation between malignant disease and venous thromboembolism. An increased incidence of venous thromboembolism in patients with known cancers has been convincingly demon...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 1992-10, Vol.327 (16), p.1128-1133
Hauptverfasser: Prandoni, Paolo, Lensing, Anthonie W.A, Büller, Harry R, Cogo, Alberto, Prins, Martin H, Cattelan, Anna M, Cuppini, Stefano, Noventa, Franco, ten Cate, Jan W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1133
container_issue 16
container_start_page 1128
container_title The New England journal of medicine
container_volume 327
creator Prandoni, Paolo
Lensing, Anthonie W.A
Büller, Harry R
Cogo, Alberto
Prins, Martin H
Cattelan, Anna M
Cuppini, Stefano
Noventa, Franco
ten Cate, Jan W
description SINCE the initial observation by Trousseau in 1868 relating thrombotic phenomena to cancer, 1 numerous studies have addressed the relation between malignant disease and venous thromboembolism. An increased incidence of venous thromboembolism in patients with known cancers has been convincingly demonstrated. Thus, cohort studies of surgical patients that used mandatory objective tests to confirm the presence of postoperative venous thrombosis showed that the incidence of venous thrombosis was markedly higher in patients with malignant disorders than in patients with other (nonmalignant) diseases. 2 , 3 Furthermore, an increased risk of venous thromboembolism is suggested by the high incidence of pulmonary embolism and subclinical activation . . .
doi_str_mv 10.1056/NEJM199210153271604
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73189706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>5598058</sourcerecordid><originalsourceid>FETCH-LOGICAL-c570t-b30ddd3f2e1acfac5107d9963622522e13275e79b3c00567dcdc8a59830bdb573</originalsourceid><addsrcrecordid>eNp9kV1LwzAUhoMoc05_gQhFxRup5qNpmkuZc06mXmx6W9IkxY6lnUl7sX_vkQ0FUXOTkPc57_lC6JjgK4J5ev00engkUlKCCWdUkBQnO6gPbxYnCU53UR9jmsWJkGwfHYSwwHBIInuoRzjNKM76aHxr7Sp-tVUdzd9844omVCFStYnaNxtNal0ZW2sbNWU064pg3ztbt9Fs7VZt41Rb6WioQPeHaK9Uy2CPtvcAvdyN5sP7ePo8ngxvprHmArdxwbAxhpXUEqVLpTnBwkiZspRSTuEX-uBWyIJpDC0Ko43OFJcZw4UpuGADdLHxXfkGaglt7qqg7XKpatt0IReMZFLgFMDTH-Ci6XwNteWUMglWYDpAZ39BBOQk4SJjQLENpX0TgrdlvvKVU36dE5x_biL_ZRMQdbL17gpnzXfMZvSgn291FbRalh7mWIUvLGESvCRglxvMuZDXduH-TfoBxj6ZxQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1983445783</pqid></control><display><type>article</type><title>Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer</title><source>MEDLINE</source><source>EZB Electronic Journals Library</source><source>New England Journal of Medicine</source><creator>Prandoni, Paolo ; Lensing, Anthonie W.A ; Büller, Harry R ; Cogo, Alberto ; Prins, Martin H ; Cattelan, Anna M ; Cuppini, Stefano ; Noventa, Franco ; ten Cate, Jan W</creator><creatorcontrib>Prandoni, Paolo ; Lensing, Anthonie W.A ; Büller, Harry R ; Cogo, Alberto ; Prins, Martin H ; Cattelan, Anna M ; Cuppini, Stefano ; Noventa, Franco ; ten Cate, Jan W</creatorcontrib><description>SINCE the initial observation by Trousseau in 1868 relating thrombotic phenomena to cancer, 1 numerous studies have addressed the relation between malignant disease and venous thromboembolism. An increased incidence of venous thromboembolism in patients with known cancers has been convincingly demonstrated. Thus, cohort studies of surgical patients that used mandatory objective tests to confirm the presence of postoperative venous thrombosis showed that the incidence of venous thrombosis was markedly higher in patients with malignant disorders than in patients with other (nonmalignant) diseases. 2 , 3 Furthermore, an increased risk of venous thromboembolism is suggested by the high incidence of pulmonary embolism and subclinical activation . . .</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJM199210153271604</identifier><identifier>PMID: 1528208</identifier><identifier>CODEN: NEJMAG</identifier><language>eng</language><publisher>Boston, MA: Massachusetts Medical Society</publisher><subject>Aged ; Biological and medical sciences ; Cancer ; Cardiovascular disease ; Female ; Follow-Up Studies ; Hematologic and hematopoietic diseases ; Humans ; Male ; Medical research ; Medical sciences ; Middle Aged ; Neoplasms - etiology ; Other diseases. Hematologic involvement in other diseases ; Recurrence ; Thromboembolism - complications ; Thrombophlebitis - complications ; Thrombosis</subject><ispartof>The New England journal of medicine, 1992-10, Vol.327 (16), p.1128-1133</ispartof><rights>1993 INIST-CNRS</rights><rights>Copyright Massachusetts Medical Society Oct 15, 1992</rights><rights>Copyright Massachusetts Medical Society, Publishing Division Oct 15, 1992</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c570t-b30ddd3f2e1acfac5107d9963622522e13275e79b3c00567dcdc8a59830bdb573</citedby><cites>FETCH-LOGICAL-c570t-b30ddd3f2e1acfac5107d9963622522e13275e79b3c00567dcdc8a59830bdb573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJM199210153271604$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJM199210153271604$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4391539$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1528208$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prandoni, Paolo</creatorcontrib><creatorcontrib>Lensing, Anthonie W.A</creatorcontrib><creatorcontrib>Büller, Harry R</creatorcontrib><creatorcontrib>Cogo, Alberto</creatorcontrib><creatorcontrib>Prins, Martin H</creatorcontrib><creatorcontrib>Cattelan, Anna M</creatorcontrib><creatorcontrib>Cuppini, Stefano</creatorcontrib><creatorcontrib>Noventa, Franco</creatorcontrib><creatorcontrib>ten Cate, Jan W</creatorcontrib><title>Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>SINCE the initial observation by Trousseau in 1868 relating thrombotic phenomena to cancer, 1 numerous studies have addressed the relation between malignant disease and venous thromboembolism. An increased incidence of venous thromboembolism in patients with known cancers has been convincingly demonstrated. Thus, cohort studies of surgical patients that used mandatory objective tests to confirm the presence of postoperative venous thrombosis showed that the incidence of venous thrombosis was markedly higher in patients with malignant disorders than in patients with other (nonmalignant) diseases. 2 , 3 Furthermore, an increased risk of venous thromboembolism is suggested by the high incidence of pulmonary embolism and subclinical activation . . .</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Cancer</subject><subject>Cardiovascular disease</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neoplasms - etiology</subject><subject>Other diseases. Hematologic involvement in other diseases</subject><subject>Recurrence</subject><subject>Thromboembolism - complications</subject><subject>Thrombophlebitis - complications</subject><subject>Thrombosis</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kV1LwzAUhoMoc05_gQhFxRup5qNpmkuZc06mXmx6W9IkxY6lnUl7sX_vkQ0FUXOTkPc57_lC6JjgK4J5ev00engkUlKCCWdUkBQnO6gPbxYnCU53UR9jmsWJkGwfHYSwwHBIInuoRzjNKM76aHxr7Sp-tVUdzd9844omVCFStYnaNxtNal0ZW2sbNWU064pg3ztbt9Fs7VZt41Rb6WioQPeHaK9Uy2CPtvcAvdyN5sP7ePo8ngxvprHmArdxwbAxhpXUEqVLpTnBwkiZspRSTuEX-uBWyIJpDC0Ko43OFJcZw4UpuGADdLHxXfkGaglt7qqg7XKpatt0IReMZFLgFMDTH-Ci6XwNteWUMglWYDpAZ39BBOQk4SJjQLENpX0TgrdlvvKVU36dE5x_biL_ZRMQdbL17gpnzXfMZvSgn291FbRalh7mWIUvLGESvCRglxvMuZDXduH-TfoBxj6ZxQ</recordid><startdate>19921015</startdate><enddate>19921015</enddate><creator>Prandoni, Paolo</creator><creator>Lensing, Anthonie W.A</creator><creator>Büller, Harry R</creator><creator>Cogo, Alberto</creator><creator>Prins, Martin H</creator><creator>Cattelan, Anna M</creator><creator>Cuppini, Stefano</creator><creator>Noventa, Franco</creator><creator>ten Cate, Jan W</creator><general>Massachusetts Medical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>19921015</creationdate><title>Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer</title><author>Prandoni, Paolo ; Lensing, Anthonie W.A ; Büller, Harry R ; Cogo, Alberto ; Prins, Martin H ; Cattelan, Anna M ; Cuppini, Stefano ; Noventa, Franco ; ten Cate, Jan W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c570t-b30ddd3f2e1acfac5107d9963622522e13275e79b3c00567dcdc8a59830bdb573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Cancer</topic><topic>Cardiovascular disease</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neoplasms - etiology</topic><topic>Other diseases. Hematologic involvement in other diseases</topic><topic>Recurrence</topic><topic>Thromboembolism - complications</topic><topic>Thrombophlebitis - complications</topic><topic>Thrombosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prandoni, Paolo</creatorcontrib><creatorcontrib>Lensing, Anthonie W.A</creatorcontrib><creatorcontrib>Büller, Harry R</creatorcontrib><creatorcontrib>Cogo, Alberto</creatorcontrib><creatorcontrib>Prins, Martin H</creatorcontrib><creatorcontrib>Cattelan, Anna M</creatorcontrib><creatorcontrib>Cuppini, Stefano</creatorcontrib><creatorcontrib>Noventa, Franco</creatorcontrib><creatorcontrib>ten Cate, Jan W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Proquest Health and Medical Complete</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (ProQuest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>New England Journal of Medicine</collection><collection>Biological Sciences</collection><collection>Family Health Database (ProQuest)</collection><collection>Health Management Database (ProQuest)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>ProQuest_Research Library</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prandoni, Paolo</au><au>Lensing, Anthonie W.A</au><au>Büller, Harry R</au><au>Cogo, Alberto</au><au>Prins, Martin H</au><au>Cattelan, Anna M</au><au>Cuppini, Stefano</au><au>Noventa, Franco</au><au>ten Cate, Jan W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>1992-10-15</date><risdate>1992</risdate><volume>327</volume><issue>16</issue><spage>1128</spage><epage>1133</epage><pages>1128-1133</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><coden>NEJMAG</coden><abstract>SINCE the initial observation by Trousseau in 1868 relating thrombotic phenomena to cancer, 1 numerous studies have addressed the relation between malignant disease and venous thromboembolism. An increased incidence of venous thromboembolism in patients with known cancers has been convincingly demonstrated. Thus, cohort studies of surgical patients that used mandatory objective tests to confirm the presence of postoperative venous thrombosis showed that the incidence of venous thrombosis was markedly higher in patients with malignant disorders than in patients with other (nonmalignant) diseases. 2 , 3 Furthermore, an increased risk of venous thromboembolism is suggested by the high incidence of pulmonary embolism and subclinical activation . . .</abstract><cop>Boston, MA</cop><pub>Massachusetts Medical Society</pub><pmid>1528208</pmid><doi>10.1056/NEJM199210153271604</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-4793
ispartof The New England journal of medicine, 1992-10, Vol.327 (16), p.1128-1133
issn 0028-4793
1533-4406
language eng
recordid cdi_proquest_miscellaneous_73189706
source MEDLINE; EZB Electronic Journals Library; New England Journal of Medicine
subjects Aged
Biological and medical sciences
Cancer
Cardiovascular disease
Female
Follow-Up Studies
Hematologic and hematopoietic diseases
Humans
Male
Medical research
Medical sciences
Middle Aged
Neoplasms - etiology
Other diseases. Hematologic involvement in other diseases
Recurrence
Thromboembolism - complications
Thrombophlebitis - complications
Thrombosis
title Deep-Vein Thrombosis and the Incidence of Subsequent Symptomatic Cancer
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T15%3A23%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deep-Vein%20Thrombosis%20and%20the%20Incidence%20of%20Subsequent%20Symptomatic%20Cancer&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Prandoni,%20Paolo&rft.date=1992-10-15&rft.volume=327&rft.issue=16&rft.spage=1128&rft.epage=1133&rft.pages=1128-1133&rft.issn=0028-4793&rft.eissn=1533-4406&rft.coden=NEJMAG&rft_id=info:doi/10.1056/NEJM199210153271604&rft_dat=%3Cproquest_cross%3E5598058%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1983445783&rft_id=info:pmid/1528208&rfr_iscdi=true